HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.

TSX:HLS - Post by User

HLS Therapeutics Inc

Bullboard Posts

Comment by Pat123on Apr 17, 2014 12:50am

152 Views

Post# 22461727

RE:RE:Steamboat

I own both CWL and AM as well. We are not many! CWL has a real potential to move sharply higher this year with the US job market improving. If you are looking for another deep value stock, take look at Hartco (HCI). Incredible value stock that trades at $2.90 ($2.28 in cash, no debt, $350M in sales, $40M market cap and they just put theirself on the blocks).

Good luck

Bullboard Posts

Changing Europe’s dependency on HREE from China